Biomedical engineer Joshua Doloff uses federal funding to pioneer immunotherapies that could free diabetes patients from ...

Physician-scientist Theodore Scott Nowicki, MD, PhD, an assistant professor-in-residence of pediatric hematology/oncology and microbiology, immunology, & molecular genetics at the David Geffen School ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, ...

TuHURA Biosciences ( ($HURA) ) just unveiled an update. On March 18, 2025, TuHURA Biosciences announced its intention to acquire Kineta, Inc., ...

New York, USA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight The LAG ...

AbbVie has entered a partnership and option-to-license agreement with Xilio Therapeutics to develop new tumour-activated, antibody-based immunotherapies. The initiative will include masked T-cell ...

LIfT's newly granted US patent (US 12,070,473 B2) secures robust protection for the treatment of cancer, including the use of ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

Oncologi, Inc., a clinical-stage biopharmaceutical company, announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor-targeted imm ...